Items where authors include "Kirkham, B"

Article

McInnes, IB, Mease, PJ, Kivitz, AJ et al. (9 more authors) (2020) Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 study. The Lancet Rheumatology, 2 (4). e227-e235. ISSN 2665-9913

Clunie, G, McInnes, IB, Barkham, N et al. (10 more authors) (2018) Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: A multicentre retrospective study. Rheumatology Advances in Practice, 2 (2). rky042. pp. 1-11. ISSN 2514-1775

Packham, JC, Abraham, S, Kirkham, B et al. (8 more authors) (2018) A new era for collaboration? Rheumatology, 57 (5). pp. 775-776. ISSN 1462-0324

Schett, G, Lories, RJ, D'Agostino, M-A et al. (4 more authors) (2017) Enthesitis: from pathophysiology to treatment. Nature Reviews Rheumatology, 13. pp. 731-741. ISSN 1759-4790

Conference or Workshop Item

Deodhar, A, Kirkham, B, Rahman, P et al. (6 more authors) (2020) P277 Assessment of disease activity using RAPID3 and evaluation of treatment effect of guselkumab in patients with PsA: results from a randomised placebo-controlled Phase 2 clinical trial. In: British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Cancelled.

Proceedings Paper

Gossec, L, Kirkham, B, Rahman, P et al. (4 more authors) (2018) Clinically Meaningful Improvement in Health-Related Quality of Life and the Association with Disease Activity in Psoriatic Arthritis after Treatment with Guselkumab: Results from a Randomized Placebo-Controlled Phase II Clinical Trial. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .